Showing results (161-170 of 243) with videos related to

Sort By:
Pageof 25
The American Journal of Surgical Pathology|September 14, 2018
Cyclin D1-positive Mediastinal Large B-Cell Lymphoma With Copy Number Gains of CCND1 Gene: A Study of 3 Cases With Nonmediastinal DiseaseBo-Jung Chen, Philippe Ruminy, Christine G Roth, et al.
Blood|February 8, 2007
The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cellsLaurence de Leval, David S Rickman, Caroline Thielen, et al.
Frontiers in Immunology|March 12, 2025
Cellular and molecular determinants mediating the dysregulated germinal center immune dynamics in systemic lupus erythematosusSpiros Georgakis, Kalliopi Ioannidou, Bernat Bramon Mora, et al.
Viruses|December 28, 2021
Decreased Fetal Movements: A Sign of Placental SARS-CoV-2 Infection with Perinatal Brain InjuryGuillaume Favre, Sara Mazzetti, Carole Gengler, et al.
The American Journal of Surgical Pathology|October 18, 2012
Follicular peripheral T-cell lymphoma expands the spectrum of classical Hodgkin lymphoma mimicsJulien Moroch, Christiane Copie-Bergman, Laurence de Leval, et al.
Histopathology|November 21, 2023
Angioimmunoblastic T-cell lymphoma and Kaposi sarcoma: A fortuitous collision?Elsa Poullot, Dina Milowich, François Lemonnier, et al.
Blood|July 5, 2012
Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parametersFrançois Lemonnier, Lucile Couronné, Marie Parrens, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 22, 2009
Immunomodulator agent-related lymphoproliferative disordersRobert P Hasserjian, Steve Chen, Sherrie L Perkins, et al.
Blood|January 5, 2012
IDH2 mutations are frequent in angioimmunoblastic T-cell lymphomaRob A Cairns, Javeed Iqbal, François Lemonnier, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 20, 2019
18F-FDG PET metabolic-to-morphological volume ratio predicts PD-L1 tumour expression and response to PD-1 blockade in non-small-cell lung cancerMario Jreige, Igor Letovanec, Kariman Chaba, et al.
Pageof 25